DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Biapenem is an investigational drug.
There have been 4 clinical trials for Biapenem. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.
The most common disease conditions in clinical trials are Bacterial Infections, Neoplasm Metastasis, and [disabled in preview]. The leading clinical trial sponsors are Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company), Haining Health-Coming Biotech Co., Ltd., and [disabled in preview].
There are seven hundred and forty-four US patents protecting this investigational drug and four international patents.
Recent Clinical Trials for Biapenem
|Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination||Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||Phase 1|
|Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects||Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||Phase 1|
Top disease conditions for Biapenem
Top clinical trial sponsors for Biapenem
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Biapenem||Start Trial||Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders||Dana-Farber Cancer Institute, Inc. (Boston, MA)||Start Trial|
|Biapenem||Start Trial||Cyclic boronic acid ester derivatives and methods of making the same||Rempex Pharmaceuticals, Inc. (San Diego, CA)||Start Trial|
|Biapenem||Start Trial||Methods of treating inflammation associated airway diseases and viral infections||WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Biapenem||European Patent Office||2528893||2030-01-29||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|